According to the global women’s health diagnostics market report by IMARC Group, the market reached a value of US$ 21.62 Billion in 2021. It is projected to reach US$ 35.7 Billion by 2027, exhibiting at a CAGR of 8.10% during 2022-2027.
Women’s health diagnostics refers to the diagnosis and treatment of various biological and psychosocial conditions among female patients. It assists in analyzing and detecting several health issues, such as birth control, gynecologist disorders, breast cancer, sexually transmitted infections, osteoporosis, heart disease, pregnancy and childbirth, and other benign conditions.
Women’s Health Diagnostics Industry Trends and Drivers:
The global market is majorly driven by the rising incidences of chronic and lifestyle-related disorders. Furthermore, the increasing number of imaging and diagnostic centers on the global level represents another major factor influencing the market positively. Along with this, the growing health awareness among the female population regarding the benefits of early diagnosis is creating a positive outlook for the market.
Moreover, the increasing number of patients with ovarian, breast, and cervical cancer across the globe has increased the demand for accurate and effective diagnostics, which, in turn, is contributing to the market growth.
Additionally, the rising rates of infertility among the female population and the increasing prevalence of various pregnancy-related complications are propelling the need for women’s health diagnostics solutions.
Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/womens-health-diagnostics-market/requestsample
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Abbott Laboratories
Becton Dickinson and Company
bioMérieux SA
Cardinal Health Inc.
Cook Group Incorporated
F. Hoffmann-La Roche AG
General Electric Company
Hologic Inc.
Koninklijke Philips N.V.
Perkinelmer Inc.
Quest Diagnostics Inc.
Siemens AG and Thermo Fisher Scientific Inc.
The report has segmented the market on the basis of region, type, application and end user.
Breakup by Type:
- Diagnostic Devices
- Biopsy Device
- Imaging and Monitoring Devices
- Accessories and Consumables
- Diagnostic Tests
- Breast Cancer Testing
- PAP Smear and HPV Test
- Pregnancy Testing and Ovulation Testing
- Others
Breakup by Application:
- Breast Cancer
- Infectious Disease Testing
- Osteoporosis Testing
- Pregnancy and Fertility Testing
- Sexually Transmitted Disease Testing
- Others
Breakup by End User:
- Hospital and Diagnostics Centers
- Home Care
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan,India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France,United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022- 2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
Also read: Supplements that can help you live a healthier
